Breaking News Instant updates and real-time market news.

VRNS

Varonis

$53.90

1.5 (2.86%)

10:42
02/13/18
02/13
10:42
02/13/18
10:42

Varonis price target raised to $63 from $52 at Imperial Capital

Imperial Capital analyst Megan Barnett maintained an Outperform rating on Varonis and raising her price target to $63 from $52 based on the firm's growth outlook following Varonis's Q4 results that exceeded both Imperial's and consensus estimates.

  • 26

    Feb

  • 29

    Mar

VRNS Varonis
$53.90

1.5 (2.86%)

02/13/18
RBCM
02/13/18
NO CHANGE
Target $63
RBCM
Outperform
Varonis price target raised to $63 from $55 at RBC Capital
RBC Capital analyst Matthew Hedberg raised his price target on Varonis to $63, saying the company's Q4 earnings were highlighted by sizable upside to revenue and profitability thanks to the "large deal success as well as +50% growth from EMEA". Hedberg believes that FY18 outlook was likely conservative and will be revised higher as the year progresses, keeping his Outperform rating on Varonis.
02/12/18
JEFF
02/12/18
NO CHANGE
JEFF
Varonis Q4 results expected to be in-line, says Jefferies
Jefferies analyst John DiFucci sees Varonis' Q4 results to be in-line with management guidance and consensus expectations. DiFucci noted that investors will be paying close attention to the company's progress in continuing to improve sales execution in the U.S., and to extend this to Europe. Jefferies kept a Buy rating and $55 price target on Varonis shares.
01/19/18
NEED
01/19/18
NO CHANGE
Target $65
NEED
Buy
Varonis price target raised to $65 from $52 at Needham
Needham analyst Alex Henderson raised his price target on Varonis to $65 and kept his Buy rating after the Needham Growth Conference meetings with the management. Henderson says the company's presentation boosted his confidence in the outlook and growth potential for Varonis, with stronger up-sell, larger account penetration, and ample room for more customer wins.
12/05/17
OPCO
12/05/17
INITIATION
Target $57
OPCO
Outperform
Varonis initiated with an Outperform at Oppenheimer
Oppenheimer initiated Varonis with an Outperform rating and $57 price target, making the case that its platform offers robust features and unique functions that differentiate it from traditional data security offerings.

TODAY'S FREE FLY STORIES

IT

Gartner

$148.85

3.89 (2.68%)

08:16
10/15/18
10/15
08:16
10/15/18
08:16
Conference/Events
Gartner to hold a symposium »

Gartner Symposium: ITxpo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 08

    Nov

QQQ

Invesco QQQ Trust

$174.28

4.59 (2.70%)

08:16
10/15/18
10/15
08:16
10/15/18
08:16
Technical Analysis
Invesco QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPG

Interpublic Group

$21.41

-0.19 (-0.88%)

08:16
10/15/18
10/15
08:16
10/15/18
08:16
Initiation
Interpublic Group initiated  »

Interpublic Group resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

$COMP

Nasdaq Composite

$0.00

(0.00%)

08:16
10/15/18
10/15
08:16
10/15/18
08:16
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNSDF

Renault

$0.00

(0.00%)

08:16
10/15/18
10/15
08:16
10/15/18
08:16
Downgrade
Renault rating change  »

Renault downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$130.79

8.61 (7.05%)

08:16
10/15/18
10/15
08:16
10/15/18
08:16
Hot Stocks
Sarepta signs license agreement with Lysogene for LYS-SAF302 »

Sarepta announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDX

Nasdaq 100 Index

$0.00

(0.00%)

08:16
10/15/18
10/15
08:16
10/15/18
08:16
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDAIF

Daimler AG

$0.00

(0.00%)

08:16
10/15/18
10/15
08:16
10/15/18
08:16
Downgrade
Daimler AG rating change  »

Daimler AG downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PARR

Par Pacific

$18.80

-0.08 (-0.42%)

08:15
10/15/18
10/15
08:15
10/15/18
08:15
Conference/Events
Argus to hold a summit »

Fuel Oil Summit will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEG

PSEG

$53.70

0.1 (0.19%)

, RNR

RenaissanceRe

$131.69

-1.45 (-1.09%)

08:15
10/15/18
10/15
08:15
10/15/18
08:15
Conference/Events
Deutsche Bank to hold a conference »

ESG Investing Conference…

PEG

PSEG

$53.70

0.1 (0.19%)

RNR

RenaissanceRe

$131.69

-1.45 (-1.09%)

DB

Deutsche Bank

$10.84

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 11

    Nov

  • 14

    Nov

08:15
10/15/18
10/15
08:15
10/15/18
08:15
General news
U.S. retail sales preview: »

U.S. retail sales…

08:15
10/15/18
10/15
08:15
10/15/18
08:15
General news
Empire State Mfg Survey General Business Conditions Index to be reported at 08:30 »

October Empire State Mfg…

08:15
10/15/18
10/15
08:15
10/15/18
08:15
General news
Retail Sales less autos to be reported at 08:30 »

September Retail Sales…

08:15
10/15/18
10/15
08:15
10/15/18
08:15
General news
Retail Sales to be reported at 08:30 »

September Retail Sales…

ADBE

Adobe

$248.89

10.24 (4.29%)

08:14
10/15/18
10/15
08:14
10/15/18
08:14
Conference/Events
Adobe to hold a conference »

Adobe MAX is being held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

AIMT

Aimmune

$26.40

1.23 (4.89%)

, REGN

Regeneron

$384.20

12.47 (3.35%)

08:12
10/15/18
10/15
08:12
10/15/18
08:12
Hot Stocks
Aimmune Therapeutics announces initiation of Phase 2 study of AR101 »

Aimmune Therapeutics…

AIMT

Aimmune

$26.40

1.23 (4.89%)

REGN

Regeneron

$384.20

12.47 (3.35%)

SNY

Sanofi

$42.89

-0.83 (-1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

  • 13

    May

SVRA

Savara

$9.94

-0.08 (-0.80%)

08:11
10/15/18
10/15
08:11
10/15/18
08:11
Hot Stocks
Savara completes enrollment of IMPALA Phase 3 study »

Savara announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

KRYS

Krystal Biotech

$15.49

0.58 (3.89%)

08:10
10/15/18
10/15
08:10
10/15/18
08:10
Conference/Events
Krystal Biotech to hold a conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMAX

Imax

$23.04

0.13 (0.57%)

08:10
10/15/18
10/15
08:10
10/15/18
08:10
Hot Stocks
Imax names Megan Colligan President, IMAX Entertainment and Executive VP, IMAX »

IMAX appointed Megan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 14

    Nov

XYF

X Financial

$9.55

0.05 (0.53%)

08:10
10/15/18
10/15
08:10
10/15/18
08:10
Initiation
X Financial initiated  »

X Financial initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEN

Lennar

$43.15

-0.16 (-0.37%)

08:09
10/15/18
10/15
08:09
10/15/18
08:09
Recommendations
Lennar analyst commentary  »

Lennar price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MANT

ManTech

$56.51

0.74 (1.33%)

08:09
10/15/18
10/15
08:09
10/15/18
08:09
Hot Stocks
ManTech awarded $45M contract for NSWC »

ManTech announced a $45M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

TXT

Textron

$65.07

-0.015 (-0.02%)

, BRK.A

Berkshire Hathaway

$310,740.00

2727.91 (0.89%)

08:09
10/15/18
10/15
08:09
10/15/18
08:09
Hot Stocks
Textron Aviation, NetJets announce agreements for option to expand fleet »

Textron Aviation, a…

TXT

Textron

$65.07

-0.015 (-0.02%)

BRK.A

Berkshire Hathaway

$310,740.00

2727.91 (0.89%)

BRK.B

Berkshire Hathaway

$206.72

1.41 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

KTOS

Kratos Defense

$12.99

-0.04 (-0.31%)

, HRS

Harris

$154.88

0.61 (0.40%)

08:07
10/15/18
10/15
08:07
10/15/18
08:07
Hot Stocks
Kratos licenses CDL waveforms for use in Harris' nanoSVDL radios »

Kratos Defense &…

KTOS

Kratos Defense

$12.99

-0.04 (-0.31%)

HRS

Harris

$154.88

0.61 (0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

CRON

Cronos Group

$9.86

0.82 (9.07%)

08:07
10/15/18
10/15
08:07
10/15/18
08:07
Hot Stocks
Cronos Group partners with Technion R&D Foundation for skin-care treatments »

Cronos Group has entered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.